Log In or Register to Join The Conversation!

This topic is empty.

  • Author
    Posts
    • #23112
      Michael Morale
      Keymaster

       

      Hey everyone! Hope you’re all staying safe and healthy out there.

      In this episode of the Morale Monologue, I discuss a recent decision by the FDA regarding Roche/Genentech’s experimental SMA therapy risdiplam. Recently, Roche/Genentech submitted additional data to the FDA to include older patients. This data also includes patients’ ability to receive this treatment, if and when the FDA approves it. I include information regarding why the FDA has decided to push the decision regarding risdiplam to August. I also talk about why I think this was a good decision by both Roche/Genentech, and the FDA.

       

      NOTE:  In my video, I state that I’m linking an article that was written by SMA News Today regarding this topic. However, there are two articles. Please read both articles and share them with your family and friends, and also your doctors.

       

       

      =================================

      First article

      Second article

      ==================================

       

       

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2021 All rights reserved.